Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/25225

Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding
Carulla, Patricia; Bribián Arruego,Ana; Rangel Rincones, Alejandra Helena; Gavín Marín, Rosalina; Ferrer, Isidro (Ferrer Abizanda); Caelles Franch, Carme; Río Fernández, José Antonio del; Llorens, Franc
Universitat de Barcelona
Cellular prion protein (PrPC) is a glycosyl-phosphatidylinositol¿anchored glycoprotein. When mutated or misfolded, the pathogenic form (PrPSC) induces transmissible spongiform encephalopathies. In contrast, PrPC has a number of physiological functions in several neural processes. Several lines of evidence implicate PrPC in synaptic transmission and neuroprotection since its absence results in an increase in neuronal excitability and enhanced excitotoxicity in vitro and in vivo. Furthermore, PrPC has been implicated in the inhibition of N-methyl-D-aspartic acid (NMDA)¿mediated neurotransmission, and prion protein gene (Prnp) knockout mice show enhanced neuronal death in response to NMDA and kainate (KA). In this study, we demonstrate that neurotoxicity induced by KA in Prnp knockout mice depends on the c-Jun N-terminal kinase 3 (JNK3) pathway since Prnpo/oJnk3o/o mice were not affected by KA. Pharmacological blockage of JNK3 activity impaired PrPC-dependent neurotoxicity. Furthermore, our results indicate that JNK3 activation depends on the interaction of PrPC with postsynaptic density 95 protein (PSD-95) and glutamate receptor 6/7 (GluR6/7). Indeed, GluR6¿PSD-95 interaction after KA injections was favored by the absence of PrPC. Finally, neurotoxicity in Prnp knockout mice was reversed by an AMPA/KA inhibitor (6,7-dinitroquinoxaline-2,3-dione) and the GluR6 antagonist NS-102. We conclude that the protection afforded by PrPC against KA is due to its ability to modulate GluR6/7-mediated neurotransmission and hence JNK3 activation.
Prions
Malalties per prions
Prions
Prions diseases
cc-by-nc-sa, (c) Carulla et al., 2011
http://creativecommons.org/licenses/cc-by-nc-sa/3.0/es
Artículo
info:eu-repo/semantics/publishedVersion
American Society for Cell Biology
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Carulla, Patricia; Bribián Arruego,Ana; Rangel Rincones, Alejandra Helena; Gavín Marín, Rosalina; Ferrer, Isidro (Ferrer Abizanda); Caelles Franch, Carme; Río Fernández, José Antonio del; Llorens, Franc
Rangel Rincones, Alejandra Helena; Madronal, Noelia; Gruart i Massó, Agnès; Gavín Marín, Rosalina; Llorens, Franc; Sumoy, Lauro; Torres, Juan María; Delgado-García, José María; Río Fernández, José Antonio del
Bribián Arruego,Ana; Fontana, X.; Llorens, Franc; Gavín Marín, Rosalina; Reina del Pozo, Manuel; García-Verdugo, J.M.; Torres, Juan María; Castro, F. de; Río Fernández, José Antonio del
Nocentini, Sara; Reginensi, D.; Garcia, Simon; Carulla, Patricia; Moreno-Flores, M.; Wandosell, F.; Trepat Guixer, Xavier; Bribián Arruego,Ana; Río Fernández, José Antonio del
Gil, V.; Bichler, Z.; Lee, J.K.; Seira Oriach, Oscar; Llorens, Franc; Bribián Arruego,Ana; Morales, R.; Claverol-Tinture, E.; Soriano García, Eduardo; Sumoy, Lauro; Zheng, B.; Río Fernández, José Antonio del
 

Coordinación

 

Patrocinio